N.O.max ER
En vente sur le marché américain (selon le DSLD)
XYMOGEN, food supplement from the US market
N.O.max ER (XYMOGEN), a food supplement au code-barres 871149002169, is described by its US market label, recorded on 22 February 2024. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label, entered on 22 February 2024. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XYMOGEN
- Barcode
- 871149002169
- Form
- Tablet
- One serving
- 3 tablets
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Hydroxypropyl Methylcellulose, Stearic Acid, Hydroxypropyl Cellulose, Silica, Hydroxypropyl Methylcellulose, Medium Chain Triglyceride, Magnesium Stearate
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| L-Arginine Alpha-Keto-Glutarate | Other substance | 1.98 Gram(s) |
| ActiNOS | Protein | 150 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: ALAmax CR
Entered into DSLD on 24 October 2024. Retirée du marché américain le 9 April 2025 (selon le DSLD).- Active ingredient added : Alpha-Lipoic Acid (600 mg)
- Active ingredient added : Biotin (450 mcg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: Resveratin Plus
Entered into DSLD on 23 May 2024. Retirée du marché américain le 9 April 2025 (selon le DSLD).- Active ingredient added : pTeroPure (62.5 mg)
- Active ingredient added : Quercetin (250 mg)
- Active ingredient added : Trans-Resveratrol (75 mg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: ALAmax CR
Entered into DSLD on 23 August 2023. Retirée du marché américain le 8 September 2023 (selon le DSLD).- Active ingredient added : Alpha-Lipoic Acid (600 mg)
- Active ingredient added : Biotin (450 mcg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: Resveratin Plus
Entered into DSLD on 18 July 2023. Retirée du marché américain le 8 September 2023 (selon le DSLD).- Active ingredient added : Quercetin (250 mg)
- Active ingredient added : trans-Pterostilbene (62.5 mg)
- Active ingredient added : Trans-Resveratrol (75 mg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: N.O.max ER
Entered into DSLD on 18 July 2023. En vente sur le marché américain (selon le DSLD).- Same quantity, different name: Whey Peptide Fractions in this version; ActiNOS on the displayed label (150 mg)
- Same quantity, different name: Arginine Alpha-Ketoglutarate in this version; L-Arginine Alpha-Keto-Glutarate on the displayed label (1.98 Gram(s))
Official label: N.O.max ER
Entered into DSLD on 22 May 2020. Retirée du marché américain le 18 August 2022 (selon le DSLD).- Active ingredient added : Arginine Alpha-Ketoglutarate (1,980 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
- Same quantity, different name: ACTINOS2 Whey Peptide Fraction in this version; ActiNOS on the displayed label (150 mg)
Official label: Resveratin Plus
Entered into DSLD on 23 April 2020. Retirée du marché américain le 18 August 2022 (selon le DSLD).- Active ingredient added : Quercetin (250 mg)
- Active ingredient added : Trans-Pterostilbene (62.5 mg)
- Active ingredient added : Trans-Resveratrol (75 mg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: ALAmax CR
Entered into DSLD on 23 April 2020. Retirée du marché américain le 18 August 2022 (selon le DSLD).- Active ingredient added : Alpha-Lipoic Acid (600 mg)
- Active ingredient added : Biotin (450 mcg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: N.O.max ER
Entered into DSLD on 25 August 2015. Retirée du marché américain le 21 February 2018 (selon le DSLD).- Active ingredient added : Arginine Alpha-Ketoglutarate (1,980 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
- Same quantity, different name: ACTINOS2 Whey Peptide Fraction in this version; ActiNOS on the displayed label (150 mg)
Official label: Resveratin Plus
Entered into DSLD on 25 August 2015. Retirée du marché américain le 21 February 2018 (selon le DSLD).- Active ingredient added : Quercetin (250 mg)
- Active ingredient added : Trans-Pterostilbene (62.5 mg)
- Active ingredient added : Trans-Resveratrol (75 mg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Older versions (7)
Official label: ALAmax CR
Entered into DSLD on 25 August 2015. Retirée du marché américain le 21 February 2018 (selon le DSLD).- Active ingredient added : Alpha-Lipoic Acid (600 mg)
- Active ingredient added : Biotin (450 mcg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: N.O.max ER
Entered into DSLD on 25 April 2014. Retirée du marché américain le 17 February 2014 (selon le DSLD).- Active ingredient added : Arginine Alpha-Ketoglutarate (1,980 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
- Same quantity, different name: ACTINOS2 Whey Peptide Fraction in this version; ActiNOS on the displayed label (150 mg)
Official label: ALAmax CR
Entered into DSLD on 25 April 2014. Retirée du marché américain le 17 February 2014 (selon le DSLD).- Active ingredient added : Alpha-Lipoic Acid (600 mg)
- Active ingredient added : Biotin (450 mcg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: Resveratin Plus
Entered into DSLD on 25 April 2014. Retirée du marché américain le 17 February 2014 (selon le DSLD).- Active ingredient added : Quercetin (250 mg)
- Active ingredient added : Trans-Pterostilbene (62.5 mg)
- Active ingredient added : Trans-Resveratrol (75 mg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: Resveratin Plus
Entered into DSLD on 23 March 2012. Retirée du marché américain le 26 June 2012 (selon le DSLD).- Active ingredient added : Quercetin (250 mg)
- Active ingredient added : Trans-Pterostilbene (62.5 mg)
- Active ingredient added : trans-Resveratrol (75 mg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: ALAmax CR
Entered into DSLD on 23 March 2012. Retirée du marché américain le 26 June 2012 (selon le DSLD).- Active ingredient added : Alpha-Lipoic Acid (600 mg)
- Active ingredient added : Biotin (450 mcg)
- Active ingredient removed : ActiNOS (150 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
Official label: N.O.max ER
Entered into DSLD on 23 February 2012. Retirée du marché américain le 26 June 2012 (selon le DSLD).- Active ingredient added : Arginine Alpha-Ketoglutarate (1,980 mg)
- Active ingredient removed : L-Arginine Alpha-Keto-Glutarate (1.98 Gram(s))
- Same quantity, different name: ACTINOS²(R) Whey Peptide Fraction in this version; ActiNOS on the displayed label (150 mg)
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : XYMOGEN